Speculation is mounting that Johnson & Johnson could buy its Danish R&D partner Genmab, a pairing that has created the successful blood cancer drug Darzalex. J&J this year bought Swiss biotech ...
BOSTON — As the use of biologic drugs becomes more widespread, optometrists need to be aware of the downstream impacts they could have on patients’ ocular health, according to speakers here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback